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Abstract.  Cell cycle progression for postembryonic 
cells requires the activity of 3-hydroxy-3-methylglutaryl 
coenzyme A  reductase (HMG-R), the enzyme which 
catalyzes the production of the isoprenoid precursor, 
mevalonate.  In this study, we examine the require- 
ments of HMG-R activity for cell cycle progression 
during the meiotic and early mitotic divisions using 
oocytes and dividing embryos from the surf clam, 
Spisula solidissima.  Using two different inhibitors of 
HMG-R, we find that the activity of this enzyme ap- 
pears to be required at three distinct points of the cell 
cycle during meiosis.  Depending on the stage at which 
these inhibitors are added to synchronous clam cul- 
tures, a reversible cell cycle block is triggered at the 
time of activation or at metaphase of either meiosis I 
or II, whereas there is no block to the mitotic cell cy- 
cle.  Inhibition of HMG-R activity in activated oocytes 
does not affect the transient activation of p42  MAPK but 
results in a block at metaphase of meiosis I that is ac- 
companied by the stabilization of cyclins A  and B and 
p34  ~c2 kinase activity. Our results suggest that metabo- 
lites from the mevalonate biosynthetic pathway can act 
to influence the process of activation,  as well as the 
events later in the cell cycle that lead to cyclin pro- 
teolysis and the exit from M phase during clam 
meiosis. 
p 
ROGRESS through the cell cycle of postembryonic cells 
requires  the  activity of 3-hydroxy-3-methylglutaryl 
coenzyme A  reductase (HMG-R)  t (for reviews  see 
Goldstein  and Brown,  1990;  Maltese,  1990).  HMG-R is 
a microsomal  enzyme  which  catalyzes  the  reduction  of 
3-hydroxy-3-methylglutaryl  coenzyme A  (HMG-CoA)  to 
mevalonate,  an essential  precursor required for the biosyn- 
thesis of several vital end products, which include:  choles- 
terol and other sterols,  important for membrane replication 
and  structure;  dolichol,  required  for  N-linked  protein 
glycosylation;  isopentenyladenine,  which is present in some 
types of tRNAs; and the isoprenoid side-chains  of ubiqui- 
none and heme-a, which are involved in electron transport 
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of the mitochondrial  respiratory chain (for reviews see Gold- 
stein  and  Brown,  1990;  Maltese,  1990).  In addition,  the 
mevalonate-derived  isoprenoids,  farnesol  (15 carbon)  and 
geranylgeranol  (20 carbon),  are moieties which are post- 
translationally  attached to a diverse set of cellular proteins. 
These proteins that become isoprenylated include the p21 ras 
protein (Casey et al.,  1989; Hancock et al.,  1989; Schafer 
et al.,  1989),  small  ras-like  GTP-binding  proteins,  the 
subunit  of trimeric GTP-binding  proteins,  nuclear lamins, 
and  yeast mating  factors  (for reviews  see Clarke,  1992; 
Schafer and Rine,  1992). In some instances the attachment 
of the isoprenyl groups has been found to be important for 
cellular  localization  and function. 
Treatment of dividing postembryonic cells with inhibitors 
of HMG-R activity triggers an arrest in the G1 phase of the 
cell  cycle  (Cornell  et  al.,  1977; Kaneko  et  al.,  1978; 
Quesney-Huneeus et al., 1979; Habenicht et al., 1980; Per- 
kins et al.,  1982; Fairbanks  et al.,  1984; Doyle and Kan- 
dutsch,  1988; Chakrabarti  and Engleman,  1991; Keyomarsi 
et al., 1991). A similar G1 arrest is triggered as well in a cell 
line containing an inactivating mutation in HMG-synthetase, 
the enzyme which produces HMG-CoA, when grown in the 
absence of mevalonate  (Sinensky  and  Logel,  1985).  The 
mevalonate requirement  for G1 traversal for these cell types 
is a requirement  for a non-sterol  product(s), since the addi- 
tion of mevalonate,  but not cholesterol,  can overcome the 
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derived compound(s) necessary for cell cycle progression in 
these cells is unknown, although a few candidates have been 
proposed including dolichol (Larsson, 1985, 1987; Kabakoff 
et al., 1990),  isopentenyladenine (Quesney-Huneeus et al., 
1980; Faust and Dice, 1991), prenylated proteins (Sinensky 
and Logel, 1985;  Maltese and Sheridan,  1987; Wolda and 
Glomset, 1988; Sepp-Lorenzino et al.,  1991), and mevalo- 
hate itself (Cuthbert and Lipsky, 1990, 1991). In addition to 
serving as positive regulatory influences in cell cycle pro- 
gression, increased intracellular levels of mevalonate, or its 
immediately derived metabolites, appear to negatively in- 
fluence the process of cell division as well (Cuthbert and 
Lipsky, 1991). 
The requirements of HMG-R activity for cell cycle pro- 
gression in mitotically dividing early embryos may be differ- 
ent than those seen for postembryonic cells. Inhibition of 
HMG-R activity does not affect the ability of early sea urchin 
embryos to divide mitotically. The requirements for HMG-R 
in these embryos are not manifested until the time of gastru- 
lation (Carson and Lennarz, 1979). Whether or not HMG-R 
activity is required for mitosis in early embryos from other 
species is not known. In addition, the requirements of HMG-R 
for progress through the meiotic cell cycle has not been ex- 
amined in detail in any biological system. 
To examine the contribution of HMG-R activity for cell 
cycle progression during meiosis and the early mitotic divi- 
sions, we have used oocytes and early embryos from the surf 
clam, Spisula solidissima. Oocytes from these animals are 
activated and induced to undergo the two meiotic divisions 
and the  subsequent mitotic divisions with exquisite  syn- 
chrony after fertilization in vitro. The mitotic cell cycle of 
early embryos, which is  much more  simple than that of 
postembryonic cells, is driven by the periodic activation and 
inactivation of the p34  ~c2 protein kinase, which is required 
for entry into M phase and exit from M phase, respectively 
(for review see Murray and Kirschner, 1989; Nurse, 1990). 
The  activation  and  inactivation  of  the  p34  ~¢2  kinase  is 
driven by the periodic accumulation and destruction of the 
cyclin proteins, which were first discovered in early embryos 
of sea urchins and clams as a class of proteins, the levels of 
which change dramatically as a  function of the cell cycle 
(Evans et al., 1983). The cyclins steadily accumulate during 
interphase of each cell cycle until late M phase, when they 
are specifically destroyed. The cyclins act to drive the em- 
bryonic cell cycle by forming complexes with the p34  ~dc2 ki- 
nase, which is a necessary event to initiate its activity and 
to drive the entry into M phase. At the end of M phase, the 
cyclins are proteolyzed, an event that is required for the inac- 
tivation of the p34  ~2 kinase and the exit from M phase. In 
clams,  there  are  two  cyclins,  A  and  B,  that  have  been 
identified and the manner in which the levels of these pro- 
teins change during the meiotic and mitotic cell cycles has 
been elucidated (Swenson et al.,  1986;  Westendorf et al., 
1989).  Both clam cyclins A and B bind to p34  edge, in sepa- 
rate complexes, to initiate its activation (Draetta et al., 1989; 
Parker et al.,  1991; Roy et al.,  1991). 
The meiotic cell cycle is different than the mitotic, em- 
bryonic cell cycle in that, during the specialized meiotic divi- 
sions, two rounds of M phase take place without an interven- 
ing period of DNA synthesis. As for the mitotic divisions, 
the entry into M phase of each meiotic division is preceded 
by the activation of cyclin/p34  cdc2 kinase complexes, and the 
exit of this phase is correlated with a preceding loss of activ- 
ity of these complexes. In some species, additional protein 
components have been identified, which are functional dur- 
ing meiosis but not mitosis (Sagata et al., 1988), that affect 
the activation and inactivation of cyclin/p34  ~2 complexes. 
A very early event that occurs in clam oocytes, after fertil- 
ization, is the activation of a 42-kD mitogen-activated pro- 
tein kinase (p42MAP~; Shibuya et al., 1992). This enzyme is 
activated as a consequence of phosphorylation on a tyrosine, 
as well as a threonine residue (for review see Cobb et al., 
1991; Thomas,  1992).  In fertilized or parthenogenetically 
activated clam  oocytes,  p42  MAPK becomes  tyrosine phos- 
phorylated and activated as a transient, one-time early event, 
and then is inactivated by the time of meiosis I (Shibuya et 
al.,  1992). 
In this study, two different inhibitors of HMG-R were used 
to examine the requirements of this enzyme activity at the 
time of clam oocyte activation and during the subsequent 
meiotic and mitotic cell cycles. We find that HMG-R activity 
appears to be required at three distinct points of  the cell cycle 
during meiosis, but not mitosis. The effects of these inhibi- 
tots on the transient activation of p42 MAP~ and on the chang- 
ing levels  of the cyclins and p34  ~2 kinase activity during 
the meiotic cell cycle are examined as well. 
Materials and Methods 
Clam Cultures and Sample Collection 
Spisula solidissima oocytes and sperm were collected and fertilization was 
carried out as described by Westendorf et al. (1989).  Oocytes  were sus- 
pended at a concentration of 40,000/ml  in filtered sea water and cultured 
at 18°C. To parthenogenetically  activate, KC1 (40 raM) was added to oocyte 
cultures.  In most cases,  cells from these cultures,  after germinal vesicle 
breakdown (GVBD),  were pelleted and suspended in an equal volume of 
fresh, filtered sea water. Progress through the cell cycle was monitored by 
lacto-orcein staining of fixed cells (Kuriyama et al.,  1986; Westendorf et 
al., 1989; Hunt et al., 1992), which were visualized by bright-field micros- 
copy. Culture samples to be used for immunoblotting or kinase assays were 
collected into ice-cold  calcium-free  sea water,  centrifuged  briefly  in a 
microfuge,  and the cell pellet was isolated  and flash-frozen in liquid Ne. 
Samples to be used for immunoblotting were thawed by dissolving in hot 
sample buffer  (Laemmli,  1970)  to  a  final  cell concentration of "0500 
celis/~l. Samples (10/~1) were loaded for SDS-PAGE followed by immuno- 
blotting,  as described below. Frozen samples, collected  for kinase assays, 
were homogenized in T buffer (300 mM glycine, 120 rnM K-gluconate,  100 
mM taurine,  100 mM  Hepes,  40 mM  NaC1, 15 mM  MgCI2, 20 mM 
EGTA; adjusted to pH to 7.3 with KOH) containing 0.5% NP-40,  10 mM 
NaF,  40 raM/~-glycerophosphnte,  1 mM Na-vanadate,  chymostatin (2.5 
/~g/ml),  leupeptin (2.5  t~g/ml), antipain (2.5  /~g/ml), pepstatin A  (2.5 
~g/ml), and PMSF (15/~g/ml),  to a final cell concentration of ,0200,000 
cells/mi, by passage twenty times through a 26.5-g needle attached to a 1-cc 
syringe.  Homogenates  were cleared by centrifugation at top-speed (16000 
g) in a microfuge for 5 rain at 4°C and the supernatants collected  on ice. 
lmmune/A~inity Precipitations and Kinase Assays 
Extracts were assayed for histone H1 or MBP phosphorylating activities 
directly by incubating 10/~1 (I0/~g of protein) of the cleared supernatant, 
prepared as described above, with 10 ~1 of kinase buffer containing 40 mM 
Hepes-NaOH (pH 7.3),  10 mM EGTA, 20 mM MgCI2, 0.2 mg/mi myelin 
basic protein (Sigma Chem. Co., St. Louis, MO) or 0.2 mg/mi histone H1 
(Boehringer Mannheim  Biochemieals,  Indianapolis, IN), 10 ~M protein ki- 
nase A peptide inhibitor (Sigma Chemical Co.), 0.5 mCi/ml [3,-32P]ATP 
(3,000 Ci/mmol) and 200 ~M ATP (diluted 1:100 from a 2.0-raM stock pre- 
pared in 10 mM Tris-HC1, pH 7.3, and stored at -80°C) for 10 rain at 22°C. 
For the HI kinase assays, the reactions were terminated by the addition of 
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phoresed on 13% gels, which were dried and used for autoradiography.  For 
the MBP phosphorylation assays, the reactions were terminated by placing 
15 #1 of the sample onto p81 Whatman filters,  which were immediately 
placed into 1% phosphoric acid.  Filters were washed  three times in 1% 
phosphoric acid, once in aceton  e, dried, placed into scintillation fluid, and 
the cpm were measured. For immune precipitation/kinase assays,  150 #1 
(150/tg of protein) of the cle,  ared  homogenate, prepared as described above, 
was  first precleaxed  with 50 #l of a  1:1 bead-to-buffer  flurry of protein 
A-Sepharose beads (Sigma  Chemical Co.) for 1 h at 4°C with rotation. 
Beads were pelleted by a brief microfuge  spin, the supernatant removed, 
antisera (2 #l) was added, and samples were rotated overnight at 4oc. Pro- 
tein A-Sepbarose beads (50 #l of a 1:1 slurry) were added, incubated simi- 
laxly for 1 h, and the beads were then washed three times with cold buffer 
(0.5 M LiC1, 0.1 M Tris-HCl, pH 7.2) and two times with cold buffer con- 
taining 20 mM Tris-HC1, pH 7.2, 100 mM NaCI. Beads were then pelleted, 
the  supernatant removed,  and kinase assay  buffer containing 7.5  mM 
MgC12, 20 mM Tris-HCl, pH 7.2,  1 mM ZnCI2,  1 mg/ml historic HI, 0.8 
#M ATP, and 0.6 mCi/ml [~-32p]ATP (3,000 Ci/mmol) was added to the 
pellets. Samples were incubated for 10 rain at 22"C, at which time, the reac- 
tion was terminated by the addition of 60 #1 sample buffer and a 5-min boil. 
Samples were prepared for autoradiography after SDS-PAGE, as described 
above, p13  suet protein was bacterially expressed,  purified, and coupled  to 
CN-Br-Sepharose CL-4B as described by Brizuela et al. (1987). FOr affinity 
precipitation, 75 #1 of cleared homogenate was mixed with 30 #1 p13  sue1 
beads, after preclearing with protein A-Sepharose beads,  as described for 
the immune precipitations, and incubated for 1 h at 40C. Bead precipitates 
were washed, assayed for kinase activity, and analyzed by SDS-PAGE and 
autoradiography,  as described for the immune precipitations. 
lmmunoblot Analysis and Antibodies 
Aflinlty-purified  anti-cyclin A and anti-cyclin B antibodies were produced 
and characterized as described by Swenson et al. (1986) and Westendoff 
et al. (1989),  respectively.  Anti-phosphotyrosine antibodies (clone 4GI0) 
were obtained from U.B.I.  (Lake Placid,  NY). Cell pellets,  dissolved  in 
sample buffer, prepared as described above, were separated by SDS-PAGE, 
blotted onto nitrocellulose  (Towbin et al., 1979), incubated with antibodies, 
and  then  with  aikaline-phospbatase  conjugated  secondary  antibodies 
(Promega Biotec., Madison, WI), and developed according to the manufac- 
turer's instructions. 
lnhibitors 
Lovastatin and simvastatin were kindly provided by Dr. Alfred Alberts of 
Merck Sharp & Dohme Research Laboratories (Rahway, NJ). PD123588 
was a generous gift of Dr.  Roger Newton of Parke-Davis  Pharmaceutical 
Research (Ann Arbor, MI). Inhibitors (10 mM in DMSO) were added to 
clam cultures, with stirring, to final concentrations of 35 #M (Iovastatin), 
20 #M (simvastatin), or 50/~M (PD123588) Emetine (Sigma Chemical Co.) 
was stored at -20°C as a 20-raM stock solution in water and was added 
to clam cultures to a final concentration of 100 #M. 
p4C]Acetate Labeling~Analysis 
Oocytes  were suspended in Hepes-buffered  artificial  sea water (380 mM 
NaCI,  50 mM MgCI2, 30 mM Na2SO4, 10 raM KCI, 10 mM CaC12, 100 
mM Hepes-NaOH, pH 8.0) at a concentration of 57,000 cells/ml and in- 
cubated with [t4C]acetate (3/~Ci/ml; ll0 mCi/mmol; Moravek Biochemi- 
cal, Inc., Brea, CA). At the end of the labeling period, 4 ml of culture sam- 
ples were collected and washed with an excess of ice-cold calcium-free  sea 
water, centrifuged briefly and the cell pellet was isolated and flash-frozen 
in liquid N2 until analysis.  Samples were thawed by vortexing sequentially 
in 2 ml methanol, 1 ml chloroform, and 0.7 rnl H20.  An additional 1 ml 
chloroform and  1 ml H20 was  added and samples  were  centrifuged  at 
1,600 g for 5 rain, to create aqueous and organic phases (Bligh and Dyer, 
1959). 3 ml of each aqueous phase was removed, lyophilized,  resuspended 
in 100 #1 H20, and a portion of this fraction (25 #1) was analyzed by two- 
dimensional TLC  (2-D TLC) on cellulose plates developed  with 1-pro- 
panol/NH3 (25% aqueous solution)/H20 (6:3:1) in the first dimension and 
2-butanol/acetic acid/H20 (40:10:13)  in the second dimension (Beyer et 
al.,  1985).  Standards chromatographed in parallel were mevaionate,  fax- 
nesyl pyrophospbate,  geranylgeranylpyrophosphate,  HMG  CoA,  acetyl 
CoA,  acetoacetyl  CoA,  [l~2]acetate,  and isopentenylpyrophosphate.  Chro- 
matograms of labeled compounds were subjected to autoradiography and 
unlabeled standards were identified  by iodine visualization.  Radiolabaled 
chromatographic spots,  which were  subjected  to further analysis,  were 
scraped and eluted from the gel matrix with H20. A portion of eluted sam- 
ples were subjected to base treatment (0.5 N NaOH, 60"C, 1 h), neutralized 
with HCI,  lyophilized,  and  suspended  in H20  for 2-D  TLC  analysis. 
Counts-per-minute in radiolabeled chromatographic spots were determined 
by scintillation  counting after scraping  and resuspension of gel matrix in 
scintillant. 
lmmunofluorescence 
At the time of GVBD, activated clam ooeytes were pelleted and suspended 
in an equal volume of calcium-free  sea water and further incubated.  Sam- 
pies were collected and settled onto polylysine-coated  coveralips for 5 rain 
before submerging into 2 % 1,3 dichlomacetoneJacetone,  which was in a dry 
ice/methanol bath, for 10 rain. Coverslips  were rehydrated  by successive, 
3-rain incubations  in: 90, 70, 50, and 25 % acetone before placement in PBS. 
After washing  two times (5 rain) in PBS containing 0.1% Triton X-100 
(PBST),  eoverslips  were incubated in blocking buffer (2 % goat serum in 
PBST) for 30 min at room temperature.  After a 5-min wash in PBST, sam- 
pies  were  incubated  with  anti-c~-tubulin  antibody  (Amersham  Corp., 
Arlington Heights, IL) diluted 1:100 at 4"C overnight.  After washing four 
times for 10 rain in PBST (the third wash also contained 2 % goat sera), 
samples  were  incubated  with  rhodamine-labeled secondary  antibodies 
(Bochringer Mannheim  Biochemicals) at 1:100 dilution for 2 h at room tem- 
perature. After further washes (two times in PBST, one time in PBST con- 
taining 1 #g/ml HOECHST's 33342  [Caibiochem,  San Diego,  CA],  two 
times in PBS, each for 10 rain), coverslips were mounted in a solution con- 
taining 0.2 M Tris-HCl,  pH 8.5, 20% Mowiol  (Calbiochem, San Diego, 
CA), and 2.5%  1,4 diazoabieyclo[2,2,2]octane  (Sigma Chem. Co.).  Sam- 
pies were observed using a laser scanning confocal microscope (model 600; 
Bio-Rad  Laboratories, Hercules,  CA). 
Results 
Inhibitors of  HMG-CoA Reductase Activity Block 
Activation of  Clam Oocytes 
The female gamete of the surf clam is an oocyte that is ar- 
rested at prophase of  meiosis I with condensed chromosomes 
distributed within a large germinal vesicle (nucleus). Upon 
fertilization, the oocyte is activated, i.e., the cell cycle block 
is removed, and meiosis is rapidly resumed. At 10--15 min 
after  fertilization,  GVBD  occurs  synchronously and  the 
chromosomes  begin  congressing  to  form  the  metaphase 
plate for meiosis I. Meioses I and II take place in close suc- 
cession and the embryos then pr~  directly into the mi- 
totic divisions (for the timing of the meiotic cell cycle stages, 
see Fig. 5, top panel). Activation of clam oocytes can also 
be triggered parthenogenetically by treatment with KC1 (Al- 
len,  1953).  For these oocytes, GVBD and the two meiotic 
divisions occur with the same timing as seen for those acti- 
vated by fertilization. Artificially  activated oocytes, however, 
are unable to undergo the mitotic divisions due to the ab- 
sence of centrioles, which are normally acquired from the 
sperm at fertilization and which are required for the forma- 
tion of the bipolar spindles during mitosis (Kuriyama et al., 
1986). 
Although the requirements for HMG-R activity for cell cy- 
cle  progression  in  postembryonic  cells  have  been  well 
documented, the contribution of this activity in oocytes for 
initiation of the cell cycle, or in early embryos for passage 
through the meiotic and mitotic divisions have not been 
examined in detail. We first examined the effects of inhibiting 
3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG- 
R) on clam oocyte activation. Oocytes were incubated in the 
presence of the HMG-R inhibitor, lovastatin, for 15 rain, and 
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Figure  1.  Effects  of HMG-R 
inhibitors on oocyte and MAP 
kinase  activation.  (,4) Clam 
oocytes were  first  incubated 
for  15  min  in  lovastatin, 
PD123588,  an equal  volume 
of vehicle  alone (DMSO) or 
untreated sea water,  and then 
treated with KCI to activate. 
At 20 rain and 60 rain after 
KCI  addition,  oocytes  were 
examined  by bright-field  mi- 
croseo  W  and the percentage 
of those which had undergone 
GVBD were determined.  Be- 
tween  50-100  oocytes  were 
scored for each time point. In 
those cultures which were un- 
treated  (No  treatment)  or 
treated  with  vehicle  alone 
(DMSO),  100%  GVBD had 
occurred by 20 rain,  whereas 
less than 2%  GVBD had oc- 
curred in cultures treated with 
either lovastatin or PD123588 
at 20 rain or 60 rain. (B) Clam 
oocytes were incubated  for 15 
rain  in  either  lovastatin  or 
equal volumes of DMSO. Oo- 
cytes were pelleted,  washed,  and starting at 5 min after the first wash, were incubated  in fresh sea water to which KCI was added (time 
0') to activate.  At successive  5' intervals,  samples  were collected into fixative and the chromosomes stained  with lacto-orcein. Samples 
were examined by bright-field  microscopy and the percentage of oocytes which had undergone GVBD was determined.  Between 50-100 
oocytes were scored for each time point. (C) Oocytes were treated  with lovastatin or PD123588  at times before and after KC1 treatment 
and the percentage of GVBD was determined at 60 rain after addition  of KCI by bright-field  microscopy.  (D) Oocytes were treated  with 
lovastatin or equal volumes of DMSO for 15 min before the addition of KCI. At the time of KCI addition,  and at subsequent 5-rain intervals, 
samples were collected and flash frozen. Samples were thawed by homogenization in buffer and assayed for MBP phosphorylating activity. 
The resulting  filter-bound  cpm were determined for each sample. 
then treated with activating concentrations of KC1.  The oc- 
currence of  GVBD in these oocytes was monitored by bright- 
field microscopy as an assay of activation.  In control, un- 
treated cultures or those treated with vehicle alone, GVBD 
had occurred in 100% of the culture by 20 min after KC1 ad- 
dition  (Fig.  1  A).  However,  in  cultures  incubated  with 
lovastatin, less than 2 % GVBD had occurred by 60 min after 
KC1 addition. The lovastatin-induced block to GVBD was re- 
versible.  When oocytes were preincubated with lovastatin, 
washed in fresh sea water and treated with KCI, GVBD oc- 
curred with the same timing as control cultures (Fig.  1 B). 
These  results  demonstrate  that  lovastatin  can  reversibly 
block  clam  oocyte activation  and,  therefore,  suggest  that 
HMG-R activity is required for this process. 
Reversal  of the  lovastatin-induced  arrest  of KCl-treated 
oocytes by mevalonate,  the product of HMG-R would un- 
equivocally establish the requirement of HMG-R activity for 
clam oocyte activation.  However,  in experiments  in which 
lovastatin-arrested clam cultures were incubated in the pres- 
ence of [3H]mevalonate, we were unable to detect cellular 
incorporation  of 3H  (not  shown).  These  results  indicated 
that this agent was not taken up effectively by these cells, thus 
depriving this study of a desired control which would dem- 
onstrate the specificity of the lovastatin effects. The addition 
to lovastatin-arrested  clam oocytes of downstream compo- 
nents  in the mevalonate biosynthetic pathway,  cholesterol, 
dolichol,  and  Coenzyme Oo  which  are  hydrophobic com- 
pounds, like lovastatin itself,  also were unable to abrogate 
the arrest in the presence of KCl (data not shown).  These 
results,  however, are difficult to interpret in the absence of 
proof that these agents were actually being taken up. 
PD123588  LOVASTATIN 
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Figure 2. Inhibitors of HMG-R. The structures  of the two HMG-R 
inhibitors  mainly used in this  study are shown.  The structure of 
simvastatin, a third inhibitor used, is identical to that of lovastatin, 
except  for the presence of a  methyl group which displaces  the 
hydrogen at the position shown by the arrow. 
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effects on clam oocyte activation. The effects of this inhibitor 
were identical to those seen with lovastatin; oocyte  activation 
was blocked reversibly (not shown). Simvastatin is a deriva- 
tive of lovastatin and, as such, its structure is almost identi- 
cal, except for a single methyl group which is substituted in 
the side chain ester (Fig. 2). It was possible that the block 
to oocyte activation induced by these inhibitors was due to 
effects specific to these types of  compounds on unknown mo- 
lecular targets rather than to inhibition of HMG-R activity. 
To test whether or not the HMG-R inhibitor-induced block 
to activation of clam oocytes was due to the inhibition of 
HMG-R activity or to effects specific to lovastatin-like com- 
pounds on unknown targets, we examined the effects on oo- 
cyte activation with a different type of HMG-R inhibitor. For 
these experiments, we used PD123588, a compound that is 
structurally dissimilar to lovastatin (Fig. 2) and is slightly 
less active than both lovastatin and simvastatin in its effec- 
tiveness of inhibiting HMG-R in vitro (Alberts et al., 1980; 
Endo, 1980; Sliskovic et al., 1990; Endo, 1992). As was the 
case for lovastatin, PD123588 acted to block clam oocyte ac- 
tivation (Fig.  1 A). The PD123588-induced arrest was also 
readily reversed when oocytes were washed and incubated in 
the presence of fresh sea water (not shown). These results 
corroborate the notion that HMG-R activity is required for 
activation of clam oocytes and, thus, suggest that a metabo- 
lite(s) from the mevalonate biosynthetic pathway can act to 
influence this process. 
The time window in which the HMG-R inhibitors could 
act as effective  blockers of  activation was determined relative 
to the time ofKCl trealment of  oocyte cultures. For these ex- 
periments, lovastatin or PD123588 was added to cultures at 
specific times before and after KC1 addition and the per- 
centage of GVBD in these cultures was determined at 5-min 
intervals. Fig.1  C shows the results obtained by 60 min af- 
ter  KCI  treatment  for cultures  treated with  lovastatin  or 
PD123588.  Lovastatin was able to block greater than 50% 
GWBD if added any time up to 6 min after KCI treatment. 
It was completely ineffective at blocking activation if added 
after 10 min. PD123588 was effective at blocking GVBD up 
to 3 min after KCI treatment and was ineffective after 5 min. 
This difference in the time windows of oocyte sensitivity to 
these inhibitors may be due to a difference in the efficiency 
of their uptake by the cells. In these experiments, untreated 
control cultures assayed in parallel underwent GVBD syn- 
chronously between  10-15  min  after KC1  treatment  (not 
shown). These data suggest that HMG-CoA reductase activ- 
ity is required for at least 3-6 min after KC1 treatment in or- 
der for oocytes to become activated. 
An early event after fertilization or KCI treatment of clam 
oocytes is the activation of a myelin basic protein (MBP)- 
phosphorylating activity (Shibuya et al., 1992). This activity 
appears by 5 min after fertilization or KC1 activation, before 
GVBD, and is due, at least in part, to the combined activities 
of 1M2 mitogen-activated kinase and p34o~Vcyclin B com- 
plexes (Shibuya et al.,  1992). The effects of HMG-R inhibi- 
tors on activation of this MBP-phosphorylating activity after 
KCI treatment were tested. Oocyte cultures were incubated 
for 15 min in lovastatin or vehicle alone, and then treated 
with activating concentrations of KC1. Samples were col- 
lected at successive 5-min intervals from both cultures and 
used to prepare extracts, which were assayed for MBP-phos- 
phorylating activity (Fig. 1 D). In samples from control cul- 
tures,  MBP-phosphorylating activity was  stimulated by 5 
min after KCI addition. This activity was not stimulated in 
the  lovastatin-treated  culture.  These results  indicate  that 
lovastatin acts to block this early event of activation, as well 
as GVBD, and suggests that HMG-R activity is required for 
this process. 
Inhibition of  HMG-R in Oocytes Leads to a Build-Up 
of HMG-CoA 
To directly examine the components in the mevalonate bio- 
synthetic pathway that are synthesized in oocytes and the 
effects on the synthesis of these components conferred by 
HMG-R inhibition, clam oocytes were treated with lovasta- 
tin or vehicle alone (DMSO) and incubated for 60 min with 
[~4C]acetate, a small molecule that is taken up by oocytes. 
Samples were extracted to produce an organic fraction, ex- 
pected to contain the sterols and dolichol, and an aqueous 
fraction, expected to contain acetyl CoA, acetoacetyl CoA, 
HMG-CoA,  mevalonate, and other non-sterol mevalonate 
derived metabolites, as well as metabolites from the citric 
acid cycle (Bligh and Dyer, 1959). A sample containing the 
non-saponifiable simple lipids  was  prepared from the or- 
ganic fraction (Dittmer and Wells,  1969) and analyzed by 
1-D TLC with dolichol, Coenzyme Q and the sterols, choles- 
terol, squalene, and lanosterol standards analyzed in paral- 
lel.  No labeled oocyte components comigrated with these 
standards (data not shown) suggesting that these components 
are not synthesized in high levels by oocytes. These results 
were consistent with our observations that the addition of 
cholesterol, dolichol, or Coenzyme Q did not abrogate the 
block to activation in lovastatin-arrested oocytes. 
Equivalent amounts of aqueous fractions from oocyte cul- 
tures treated with lovastatin or DMSO alone and biosyntheti- 
cally labeled with [t4C]acetate were analyzed by 2-D TLC 
and autoradiography (Fig. 3, A and B). There are a number 
of radiolabeled chromatographic spots, which appear to be 
identical, that were detectable in these fractions from both 
cultures (Fig. 3,  spots 4-10).  We have not identified these 
components, but suspect them to include metabolites from 
the citric acid cycle. Radiolabeled components that cochro- 
matographed with mevalonate, isopentenyl pyrophosphate, 
farnesyl  pyrophosphate,  or  geranylgeranylpyrophosphate 
standards were not detected in either of these samples. The 
transient presence of these intermediates as they are pro- 
duced during passage through the mevalonate biosynthetic 
pathway may have rendered their detection below the limits 
of sensitivity in this analysis. 
Several labeled chromatographic spots were detected in 
the lovastatin-treated oocytes, which were not detected in 
those oocytes treated with DMSO  (Fig.  3  B;  spots 1-3). 
Spots 2 and 3 did not chromatograph with any of our stan- 
dards and remain unidentified. Spot 1, however, chromato- 
graphed in the same position as the HMG-CoA standard. To 
confirm that the radiolabeled component from spot 1 was 
HMG-CoA, this spot was scraped, eluted, and treated with 
base to disrupt the thiol ester linkage of HMG-CoA. When 
this sample was analyzed by 2-D TLC, a single radiolabeled 
component was  generated which chromatographed in  the 
same position as a radiolabeled spot from a 'q2-HMG-CoA 
standard  treated  with  base  and  analyzed in  parallel  (not 
Turner et al. HMG-CoA Reductase and the Meiotic  Cell Cycle  1149 shown). These results indicated that the radiolabcled compo- 
nent represented in spot 1 was HMG-CoA. 
To compare the synthesis of HMG-CoA, and other radio- 
labeled components from aqueous fractions, at successive 
times, oocytes were treated with lovastatin or DMSO and in- 
cubated continuously with [~4C]acetate. Samples were re- 
moved at 20 and 40 min for extraction, the aqueous fractions 
were prepared and equivalent amounts were analyzed by 2-D 
TLC and autoradiography (data not shown). Spots 1-I0 were 
scraped and the counts-per-minute (CPMs) determined by 
scintillation counting. When samples from the lovastatin and 
DMSO-treated cultures were compared, the levels of radio- 
activity in spots 2 and 4-10 either were maintained at roughly 
unchanged levels, or increased with time in similar ways 
from the two cultures (data not shown). The CPMs from 
spots I (HMG-CoA) and 3 increased dramatically over time 
in the lovastatin-treated culture samples but not from those 
treated with DMSO. The CPMs from the HMG-CoA spots 
from these cultures are shown in Fig. 3 C  These results indi- 
cate  that  oocyte  treatment  with  the  HMG-R  inhibitor, 
lovastatin, leads to the build up of HMG-CoA as well as a 
second component, and, thus, confirm that HMG-R is being 
inhibited by lovastatin in these cells. The build-up of these 
components  in  cells  treated  with the  HMG-R  inhibitors 
might be important in the effects on cell cycle progression 
that are observed. 
HMG-R Inhibitors Induce an Arrest at Metaphase of 
the Meiotic Cell Cycle of  Activated Clam Oocytes 
To examine the effects of inhibiting HMG-CoA reductase on 
cell cycle progression at times after activation, clam oocyte 
cultures were fertilized or treated with activating concentra- 
tions of KCI, allowed to Undergo GVBD and, at successive 
times, aliquots of these cultures were removed and incubated 
in the presence of  lovastatin. Samples from each aliquot were 
removed at 5-min intervals and put into fixative for chromo- 
some staining and cell cycle staging. Results from such an 
experiment in which oocytes were activated by KC1 treat- 
ment are shown in Figs. 4 and 5. 
In  the  untreated  control  culture,  chromosomes  were 
clearly visible by 5 rain after activation as tightly condensed 
bodies distributed within the germinal vesicle (Fig. 4 A). By 
10 rain, the germinal vesicle had broken down and the chro- 
mosomes had begun to congress. Congression continued un- 
til "~30 min, with the formation of the metaphase plate (an 
en face view of the metaphase plate is shown in Fig. 4 A, 30 
vain).  Anaphase of meiosis I  occurred at about this same 
time, as shown, giving rise to the first polar body. A polar 
body, which is slightly out of the plane of focus, can be seen 
in Fig. 4 A at 50 rain. The chromosomes remaining in these 
oocytes immediately realigned on the second meiotic meta- 
phase plate and anaphase of meiosis 11 occurred at about 50 
rain as shown. 
A quantitative representation of ceil cycle progression for 
the control culture is shown in Fig. 5, top panel, in which 
the  percentage  of cells  undergoing  GVBD,  anaphase  I, 
anaphase 1I,  and those with condensed chromosomes are 
plotted as a function of time. The chromosomes remained 
condensed until anaphase II was completed, whereupon they 
underwent a round of decondensation and recondensation. 
In fertilized control cell cultures,  this period of chromo- 
some decondensation represented the time of the first round 
of DNA synthesis before mitosis 1. KCl-activated cultures 
did not undergo mitosis. The chromosomes from these cul- 
tures, however, asynchronously  underwent a round of decon- 
densation  and  recondensation  starting  at  ,~100  min,  as 
Figure 3. HMG-R inhibitor treatment of clam oocytes results in increased levels of HMG CoA. (A and B) Oocytes were treated with either 
DMSO (0.6%)  or lovastatin (50 ~M) and incubated with [t4Clacetate (3 ~Ci/ml;  110 mCi/mmol) for 60 rain. Cells were washed, ex- 
tracted into an organic and aqueous fractions and equal portions of the aqueous fractions were applied to cellulose plates (O, origin). Sam- 
pies were separated by two-dimensional thin-layer chromatography and exposed for autoradiography. The metabolite represented by spot 
1 was found to be HMG CoA. I and II indicate the first and second dimensions, respectively. (C) Oocytes were treated with either DMSO 
or lovastatin and incubated with [~4C]acetate, as described for A and B. At successive times (20 and 40 min), samples were removed from 
the culture, oocytes were washed, extracted and equal portions of  the aqueous fractions were separated by 2-D TLC and exposed for autora- 
diography as described for A and B.  HMG CoA spots were scraped and the counts-per-minute were measured and plotted as shown. 
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.
 shown for the experiment represented in the top panel of 
Fig.  5. 
The chromosomes from cells which were removed from 
the control KCl-activated culture and incubated with lovasta- 
tin starting at 10.5 rain continued to congress and to form 
a metaphase plate by ,'~ 30 min, in a manner similar to con- 
trois (Fig. 4 B and Fig. 5, second panel).  At this point, how- 
ever, these ceils became arrested.  The metaphase plate in 
these cells was maintained out to the last collection point, 
which was 90 min (Fig. 5, secondpanei).  A metaphase plate 
of meiosis I from this culture is shown at 50.5 min, a time 
when control cultures were undergoing anaphase of meiosis 
II (Fig.  4  B).  When the 90-min metaphase-arrested cells 
from this culture were washed and diluted into fresh sea wa- 
ter, they went on to form polar bodies (not shown) indicating 
that this lovastatin-induced arrest was reversible. A  revers- 
ible arrest at metaphase of meiosis I was also induced in em- 
bryos from fertilized cultures treated similarly (see Fig. 6). 
Cells  that  were  removed from control  cultures  and  in- 
cubated with lovastatin starting at 21 min were not inhibited 
from undergoing anaphase of meiosis I. The timing and syn- 
chrony of anaphase in these cultures was similar to that of 
controls  (Fig.  5,  compare  third  panel  with  first  panel). 
Anaphase chromosomes from a cell in such a culture at 30 
min is shown in Fig. 4 C. After anaphase I, the chromosomes 
in these cells realigned on the metaphase plate for meiosis 
II, similar to those ceils from the control culture.  At this 
point in the cell cycle, however, they became arrested and 
maintained this metaphase plate for the duration of the ex- 
periment (Fig. 5, third panel).  A metaphase plate for meio- 
sis II, as well as the polar body from first meiosis (slightly 
out of the plane of focus) in a cell from this culture at 91 min 
can be seen in Fig, 4  C.  The metaphase arrest in these cul- 
tures was also readily reversible when cells were washed and 
placed in fresh sea water (not shown).  These same results 
were obtained from oocyte cultures activated by fertilization, 
as well (not shown). 
When aliquots from the control culture were removed and 
incubated with lovastatin at 31.5 rain, there was no effect on 
the ability of the cells to undergo meiosis II (Fig. 5, fourth 
panel).  As can be seen in Fig.  5,  there were some minor 
effects on the timing of anaphase II for this culture,  which 
was slightly delayed relative to controls (50 % of cells in the 
culture had undergone anaphase II by 56 min compared to 
48 min of controls), and on the synchrony of division, which 
was slightly lessened. The chromosomes in this culture un- 
derwent a round of decondensation and recondensation after 
meiosis II, although the timing and synchrony of these events 
were also slightly affected relative to those in control cul- 
tures.  At the  last collection point (II0 min),  the chromo- 
somes were still condensed (Fig. 5, fourth panel).  In fertil- 
ized cell cultures treated similarly, the embryos went on to 
divide mitotically, although more slowly than embryos from 
control cultures and in an asynchronous manner (not shown). 
The addition of lovastatin to an aliquot of the control cul- 
ture at 42 rain after activation had no effect on the completion 
of anaphase II or the  subsequent process of chromosome 
decondensation  and  recondensation,  which  occurred  in  a 
manner similar to the control culture (Fig.  5,  last panel). 
The chromosomes at 115 min were still condensed in this 
culture.  Embryos from fertilized cultures treated similarly 
divided mitotically. However, again, the rate of division was 
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Figure 5. Cell cycle staging of activated oocytes treated with HMG-R 
inhibitors. The cell cycle stage for culture samples collected in the 
experiment described in the legend for Fig. 3 was determined quan- 
titatively. Samples collected from control cultures (top panel), and 
those incubated with lovastatin starting at 10.5 rain (second panel), 
21 min (third panel), 31.5 rain Orourthpanel), and 42 rain (bottom 
panel) after KCI addition were examined by bright-field micros- 
copy and the percent of  cells in each which had undergone: (1) ger- 
minal vesicle breakdown (GVBD; open squares); (2) anaphase of 
meiosis I (Anaphase l;filled diamonds); (3) anaphase of meiosis 
II (Anaphase ll;filled circles); and (4) those in which the chromo- 
somes were condensed (Cond. Chrom;fiUed squares) were deter- 
mined.  Between  50-100  oocytes  were  examined  for each time 
point. Large arrowheads indicate the times at which lovastatin was 
added for each culture. 
reduced and the synchrony appeared to be lost (not shown). 
These experiments were repeated using PD123588 to in- 
hibit HMG-R instead of lovastatin and the same results were 
obtained (not shown). We have not examined in a quantita- 
tive way the effects of these inhibitors on mitotic cell cycle 
progression, except to note that incubation of embryos with 
concentrations of these  inhibitors  that block meiotic aria- 
phase do not prevent mitosis from occurring, although it ap- 
pears to occur more slowly than in untreated cultures and in 
an asynchronous manner. 
These results demonstrate that two different inhibitors of 
HMG-R induce a reversible block at metaphase during mei- 
osis in activated clam oocytes and embryos, indicating that 
HMG-R activity is required for meiotic cell cycle progres- 
sion. The activity of this enzyme appears to be required dur- 
The Journal  of Cell Biology, Volume 128,  1995  1152 ing separate time windows for the successful enactment of 
anaphase for meiosis I and II, respectively; active HMG-R 
is required sometime between 10.5 and 21 min postactivation 
for anaphase I and sometime between 21  and 31.5 min for 
anaphase II. These results suggest that a metabolite(s) from 
the mevalonate biosynthetic pathway can act at these times 
to influence the passage from metaphase to anaphase during 
the meiotic cell cycle in the clam. 
Inhibitors of  HMG-R Stabilize Cyclin Levels and 
p34  c~2 Kinase Activity 
Chromosome dynamics during  the  cell cycle is driven by 
changing levels in the activities of cyclin/p34  °~2 complexes. 
The activities of these complexes, at a basic level, is driven 
by  the  changing  levels  of the  cyclin  proteins.  We  tested 
whether the meiotic metaphase arrest induced by inhibitors 
of HMG-R was due to an effect on cyclin/p34  '~c2 activities 
and cyclin levels, or was due to a more direct effect on chro- 
mosome dynamics. For these experiments, the levels of the 
two clam cyclins, A and B, and the levels of histone H1 ki- 
nase activity, which is a measure of p34  ~dc2 kinase activity, 
was  determined  in  control,  untreated  cultures  and  those 
treated with HMG-R inhibitors. In clam embryos, new pro- 
tein synthesis is not required for activation or the proper tim- 
ing or passage through meiosis I. It is required, however, for 
the proper enactment of meiosis II (Hunt et al.,  1992).  To 
rule out potential negative effects of the HMG-R inhibitors 
on protein synthesis, we focused our efforts on analyzing the 
effects of these inhibitors during meiosis I. 
Oocytes were activated by KCI treatment or fertilization, 
allowed to undergo GVBD, and then an aliquot of the culture 
was removed and treated with one of the HMG-R inhibitors 
to induce an arrest at metaphase I. At successive times, sam- 
pies each were collected from untreated cultures and inhib- 
itor-treated cultures and processed for cell cycle staging, im- 
munoblots to determine the levels of cyclins A or B, or for 
assays of H1  kinase activity. 
Shown in Fig. 6 are the results of an experiment carded 
out using a fertilized culture which was treated with lovasta- 
tin. The immunoblots of samples reacted with anti-cyclin A 
antibodies are shown in A. As we have seen in earlier work 
(Swenson et al.,  1986),  cyclin A  was not detectable in oo- 
cytes. In control samples it appeared at ,x,20 min after fertil- 
ization and accumulated until 30 min, the time of anaphase 
I, when the levels dropped. The levels of this protein reac- 
cumulated until anaphase II (~50 min), dropped again, and 
then continued to increase at successive times to 75  min, 
which was the last time point of sample collection. In sam- 
pies treated with lovastatin starting at 12 min after fertiliza- 
tion, cyclin A was detectable starting at 22 min. The levels 
slightly  increased  by  27  min,  and  then  were  maintained 
throughout the course of the experiment. The periodic de- 
cline in the levels of this protein, due to specific degradation 
that  occurred  in  the  control  culture  was  not  seen  in  the 
lovastatin-treated culture  which  became arrested  at meta- 
phase I. 
Immunoblots of the  same  samples analyzed  in  A  were 
reacted with anti-cyclin B  antibodies (Fig.  6 B).  Cyclin B 
was detected in oocytes of the control cultures (Westendorf 
et al.,  1989).  The levels of this protein did not change ap- 
preciably at anaphase I  (30 min), increased until anaphase 
II (50 min), at which time there was a marked drop, and then 
Figure 6. Metaphase I arrest induced by HMG-R inhibitors is ac- 
companied by stabilized levds of the eyclins and histone H1 kinase 
activity. Clam oocytes were fertilized and, at 12 rain after fertiliza- 
tion, half of  the culture was removed and incubated in the continued 
presence of lovastatin. At 5-min intervals three separate  samples 
were removed from each culture. One sample was put into fix for 
chromosome staining and the other two samples were collected into 
ice  cold  calcium-free  sea water, to halt  cell  cycle progression, 
washed and flash-frozen. One set of samples was thawed directly 
into hot SDS gel electrophoresis  sample buffer and boiled for 5 
rain. The relative levels of cyclins A and B in these samples were 
determined,  after SDS-PAGE of equal amounts of protein and im- 
munoblotting by incubation with either anti-cyclin A (A) or anti- 
cyclin B (B) antibodies. The remaining set of samples was thawed 
by homogenization in buffer and assayed for histone H1 kinase ac- 
tivity. The products of this reaction (32P-labeled histone HI) were 
separated by SDS-PAGE and detected by autoradiography  (C). At 
the top of  each gel lane shown in A, B, and C is the time of  collection 
for that particular sample. Cell cycle progression for both cultures 
was quantitated by examining chromosome-stained samples at each 
time point as described in the legend for Fig. 4. The time at which 
50% of the embryos in the control culture had undergone anaphase 
of meiosis I (Ana I; 34 min) or of meiosis II (Ana II; 53 min) is 
indicated by the arrowheads in each panel. The culture treated with 
lovastatin  did  not  undergo  anaphase  but  became  arrested  at 
metaphase of meiosis I. 
reaccumulated  over time  until  the  75-min  time point.  In 
samples from the lovastatin-treated culture, the levels of cy- 
clin B appeared to remain unchanged from 17 min through- 
out 77 min, indicating that cyclin B, as for cyclin A, was sta- 
bilized by inhibition of HMG-R. 
H1 kinase activity was low in oocytes of the control cul- 
ture,  but  increased  dramatically  by  10  min,  the  time of 
GVBD (Fig. 6 C). This activity remained high until 30 min 
Turner et al. HMC_r-CoA Reductase and the Meiotic Cell Cycle  1153 Figure 7. p34  ~c2 kinase activity in immune precipitates of cyclins A or B, or in affinity precipitates with p13 beads is stabilized at high 
levels in clam embryos arrested at metaphase I arrest by HMG-R inhibitors.  Clam oocytes were activated with KCI and, at 14 min after 
KCI addition, an aliquot of the culture was removed and incubated in the presence of lovastatin. Samples from both control and lovastatin- 
treated cultures were collected at successive 5-rain intervals, as for the experiment described in the legend for Fig. 5. The chromosomes 
of fixed samples were stained and the cell cycle stage of each sample was determined quantitatively as described  in the legend for Fig. 
4. These data for the control culture are shown in A. The lovastatin-treated culture became arrested at metaphase I. Extracts from a set 
of frozen samples, which were thawed by homogenization in buffer, were split into several aliquots and were assayed for histone HI kinase 
activity either directly (B), or after immune precipitation with anti-cyclin A antibodies (C) or anti-cyclin B antibodies (D), or after affinity 
precipitation  with p13  ~  beads (E). The products of these reactions (32p-labeled histone HI) were separated by SDS-PAGE and detected 
by autoradiography  (B-E). The gel bands giving rise to the autoradiograph  shown in B-E were cut out, the counts-per-minute  (CPM) 
measured  and plotted,  as shown in the top part of each of these panels.  The time at which 50% of the embryos in the control culture 
had undergone anaphase of meiosis I (Ana I; 30 rain) or of meiosis U (Aria II; 52 rain) is indicated by the arrowheads in each panel. 
(anaphase I) when it dropped precipitously. The activity sub- 
sequently  increased  to  a  slightly  higher  level to  50  rain, 
when it again declined sharply, and then reaccumulated in 
samples  collected  until  75  min.  In  the  lovastatin-treated 
culture, H1 kinase activity was high at 17 min and was main- 
tained at a high level throughout the course of the experiment 
(Fig.  6  C). 
When these experiments were repeated using PD123588 
to  inhibit  HMG-R instead  of lovastatin,  the  same results 
were obtained  (not  shown).  Similar results  were also ob- 
tained when oocyte cultures were activated by KCI treatment 
rather than by fertilization (see Fig.  7). 
HI kinase assays provide a measure of the total p34  ~c2 ki- 
nase  activity  present  in  cellular  extracts.  We  examined 
whether  or  not  the  kinase  activity  of  subpopulations  of 
p34  °de2 present in complexes with either cyclin A  or cyclin 
B, or those which could associate with pl 3  su~ affinity beads, 
was differentially affected by the presence of HMG-R inhibi- 
tors. pl 3  ~uc~ is a protein that binds p34  ~dc2 and p34c~2-1ike ki- 
nases (Brizuela et al., 1987; Dunphy et al., 1988). It also ap- 
pears to bind, at least partially, the p42  uAPK from activated 
clam embryos (Shibuya et al.,  1992). This kinase, however, 
does not phosphorylate histone H1, which was used as a sub- 
strate in our kinase assays. These experiments were carried 
out in a similar method to that described above, except that 
oocytes were activated by KC1 treatment rather than by fertil- 
ization.  Samples were again collected for cell cycle staging 
and for HI kinase assay. In addition, samples were also col- 
lected and prepared for immune precipitation with antibod- 
ies for either cyclins A or B, or for affinity-precipitation with 
p13 Su'~ beads.  These precipitates were then assayed for ki- 
nase activity using  histone  HI  as  an  exogenous  substrate 
(Fig.  7). 
A quantitative representation of cell cycle progression is 
shown for the control culture in Fig. 7 A.  The times when 
50%  of the embryos had undergone meiotic anaphase I or 
II were •30  min and 52 min, respectively. Fig. 7 B shows 
the data from the total HI kinase assays of these samples. 
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ment represented in Fig. 6. Total HI kinase activity in these 
samples changed over time in control cultures in a manner 
similar to that seen before (compare Fig. 7 B to Fig. 6 C) 
and was stabilized at high levels in the lovastatin-treated cul- 
ture, which became arrested at metaphase I. 
In samples from control cultures, total H1 kinase activity, 
as well as that associated with each type of precipitation, 
changed over time in similar ways  (Fig.  7, B-E).  In each 
case, kinase activity was low in oocytes before fertilization, 
increased to high levels until anaphase I when there was a 
decline. After this time, the activity for H1 kinase, cyclin A 
precipitates and p13 s~cl precipitates increased slightly until 
anaphase 1I, when the levels dropped again, and then reac- 
cumulated to  higher  levels,  until  90  min  (Fig.  7,  B,  C, 
and  E).  The  levels  of activity associated  with  cyclin B 
declined at anaphase I and did not appear to reaccumulate 
before anaphase  II,  when it diminished before increasing 
again until 90 min (Fig. 7 D). 
In  samples  treated  with  lovastatin,  kinase  activity  re- 
mained  high,  increasing  slightly  over time  until  90  min 
(Fig. 7, B-E).  There was a slight decrease in the levels of 
cyclin B associated kinase activity at 32 min (Fig. 7 D). The 
decline in this activity was not due to a decrease in the levels 
of cyclin B protein. Immunoblots of cyclin B in lovastatin- 
treated cultures showed that the levels of this protein were 
unchanged at this time (Fig. 6 and data not shown). 
These  results  demonstrate  that  inhibitors  of HMG-R, 
added  to  clam  cultures  at  a  time  when  they  induce  a 
metaphase I arrest, lead to a stabilization of the levels of cy- 
clins A  and B  as well as a  stabilization of high levels of 
p34  ~a kinase activity found in complexes with cyclins A or 
B,  or that which associates with p13 =ucl beads.  This indi- 
cates that the activity of HMG-R is required during meiosis 
somewhere upstream of the biochemical processes that lead 
to cyclin destruction and loss of p34  ~c2 kinase activity nor- 
mally seen at anaphase, and suggest that a metabolite(s) from 
the mevalonate biosynthetic pathway can act to influence the 
proper enactment of these processes. 
Protein Synthesis Is Not Required  for 
Maintenance of the Metaphase I Arrest Induced 
by Inhibitors of  HMG-R 
The stabilization of the levels of cyclins A and B in embryos 
arrested at meiotic metaphase by the  HMG-R inhibitors, 
leading,  presumably,  to the  stabilization of p34~c2 kinase 
activity in these cells, could arise from either a total block 
in the activation of the cyclin destruction system, or from a 
partial block. In the latter case, it would be expected that the 
stabilized levels of the cyclins in these embryos would be due 
to continued cyclin synthesis.  To test whether the HMG- 
inhibitors were affecting a complete or partial block of the 
activation of the cyclin destruction system, we examined the 
effects of inhibiting protein synthesis on the maintenance of 
metaphase I and stabilization of histone H1 kinase activity 
in meiotic embryos arrested with lovastatin. 
An oocyte culture was incubated with emetine at a concen- 
tration that has been shown to inhibit protein synthesis (Hunt 
et al.,  1992), and then activated using KC1. At 13 min after 
KC1 treatment, an aliquot of the culture was removed and in- 
cubated with lovastatin.  Samples were taken at successive 
5-min intervals from both cultures for cell cycle staging, H1 
kinase assays, and immunoblots. 
The culture treated with emetine alone underwent GVBD 
at 13 min (not shown) and anaphase I at about 38 min (Fig. 
8). The proper enactment of anaphase II did not occur in this 
culture, an effect of emetine on clam embryos that has been 
noted by others (Hunt et al.,  1992). H1 kinase activity was 
low in oocytes, increased dramatically around the time of 
GVBD, and then declined around the time of anaphase I, as 
seen in activated cultures in the absence of  emetine (compare 
Fig. 8 to Fig. 6 C). This activity disappeared after anaphase 
I  and was  not detectable in  samples  collected to 75  min 
(Fig. 8). In immunoblots of samples from these cultures, cy- 
clin B  was  present at constant levels up until anaphase I, 
when the levels declined, and then disappeared, whereas cy- 
clin A  was  undetectable, confirming that protein synthesis 
was inhibited (not shown). 
The culture incubated with lovastatin, in addition to eme- 
tine, became arrested at metaphase I, with condensed chro- 
mosomes tightly aligned on the metaphase plate (not shown). 
This arrest was maintained for the duration of the experi- 
ment, until 77 min.  H1 kinase activity in this culture was 
maintained at a  high level, from  17 min to 77 min (Fig. 
8). Cyclin B was detected at constant levels on immunoblots 
of samples from this culture, whereas cyclin A was not de- 
tected in any of these samples (not shown). 
These data demonstrate that maintenance of the meta- 
phase I arrest induced by inhibiting HMG-R activity, does 
not require protein synthesis. In the absence of protein syn- 
thesis, the levels of ill kinase activity and cyclin B are main- 
tained. These results indicate that the cyclin destruction sys- 
tem  is  blocked  to  activation  by  inhibiting  HMG-R  and 
suggest, again, that metabolite(s) from the mevalonate bio- 
synthetic pathway can act somewhere upstream to influence 
the initiation of this process. 
Inhibition of  HMG-CoA Reductase Activity Does Not 
Affect g)¢osine Dephosphorylation of  p42  ~pr 
In fertilized or KCl-treated clam oocytes, p42  u^PK becomes 
tyrosine phosphorylated and activated as a transient, one- 
time event. The activity and tyrosine phosphorylation of this 
enzyme disappears by the time of meiosis I (Shibuya et al., 
1992). We tested whether or not the tyrosine dephosphoryla- 
tion of p42  MAPK seen in untreated clam cultures was affected 
by inhibiting HMG-R activity. For these experiments, clam 
oocytes were activated by KC1 treatment and at 13 min, after 
GVBD, an aliquot of the culture was removed and incubated 
in the presence of lovastatin to induce a metaphase I arrest. 
Samples were collected at successive 5-min intervals from 
both cultures for cell cycle staging and immunoblotting using 
anti-phosphotyrosine antibodies. 
In the control, untreated culture, tyrosine phosphorylation 
of p42  M^PK was  undetectable in the oocyte, appeared at 5 
min, reached a peak at 15 min, and then declined to unde- 
tectable levels by 30 min (Fig. 9). After this time, the tyro- 
sine phosphorylation of I>42  MAPK was  not seen in samples 
from this culture collected until 75 min.  Anaphases I and 
II took place in this culture at '~33 min and 53 min, respec- 
tively,  as  indicated  (Fig.  9).  In  the  culture  treated  with 
lovastatin, which became arrested at metaphase I, tyrosine 
phosphorylation of p42  raAPK was detected at 17 min at levels 
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metaphase I arrest or stabilization of H1 kinase activity induced by 
lovastatin treatment. Clam oocytes were incubated for 15 rain in the 
presence of emetine, and then activated by KC1 addition. At 13 min 
after KCI addition, an aliquot of the culture was removed and in- 
cubated in the presence of lovastatin. Samples from both cultures 
were collected at successive 5-rain intervals and prepared for cell 
cycle staging and HI kinase assays. The time of anaphase I for the 
culture treated with emetine alone is indicated. Cells from the cul- 
ture treated with emetine and lovastatin became stably arrested at 
metaphase  I. The products  of the  H1 kinase  assays (32p-labeled 
histone HI) were separated by SDS-PAGE  and detected by autoradi- 
ography, as shown. 
similar to that seen in the control culture (Fig. 9). The levels 
of this modification were maintained until '~27 min, when 
they declined,  disappearing by ~37 min, and were not de- 
tected again in samples collected throughout 77 min. 
Although  the  timing  of  tyrosine  dephosphorylation  of 
p42  MApK was slowed for clam cultures incubated with lova- 
statin, these data demonstrated that the removal of this modi- 
fication was not  prevented by inhibiting  HMG-R activity. 
These results indicate that the maintenance of activity and 
tyrosine phosphorylation of p42  MAPK is not required for the 
maintenance  of metaphase  I  arrest  induced  by  lovastatin 
treatment. 
Effects of  HMG-CoA Reductase Inhibition on 
Microtubule Polymerization and Spindle Formation 
For  most  types  of postembryonic  cells,  treatments  with 
agents  that  cause  microtubule  depolymerization,  such  as 
nocodazole,  induce  a  metaphase  arrest  accompanied  by 
high levels of p34  ~dc2 kinase activity and  condensed  chro- 
mosomes, similar to the arrest that we have obtained with 
meiotic clam cells treated with inhibitors of HMG-R activ- 
ity. Although not true for some species of embryonic cells, 
these same effects of microtubule depolymerizing agents are 
produced in clam embryos undergoing either meiosis or mi- 
tosis (Hunt et al., 1992; and K. Swenson, unpublished). We 
tested whether or not the metaphase arrest in clams induced 
by HMG-R inhibitors was potentially due to effects on mi- 
crotubule polymerization. 
For these experiments, clam oocytes were activated with 
KC1, treated with lovastatin at 12 rain to induce a metaphase 
I arrest, and then at 50 min were fixed, incubated with anti- 
tubulin antibodies, and prepared for indirect immunottuores- 
cence detection of microtubules by confocal microscopy. In 
these samples, polymerized microtubules present in spindle 
structures were detected (Fig. 10, A and B). These spindles, 
however, instead of  containing the usual two poles found nor- 
mally, were unusual in that they contained four poles. Fig. 
Figure 9. Lovastatin treatment of activated clam ooeytes does not 
affect tyrosine dephosphorylation  of p42 MAP kinase.  Clam oo- 
cytes were activated by KC1 treatment and, at 13 min after KCI addi- 
tion,  an aliquot of the culture was removed and incubated in the 
presence of lovastatin. Samples were collected at successive 5-min 
intervals and prepared for cell cycle staging and irnmunoblot analy- 
sis using anti-phosphotyrosine antibodies. Shown is a region of the 
immunoblot which contains the p42  MA~ protein as indicated. The 
time of anaphase I and II for the control, untreated culture is indi- 
cated.  The  lovastatin-treated  culture  became  stably  arrested  at 
metaphase I. 
10 A contains the images obtained from three different opti- 
cal sections of a single cell within which the four poles can 
be visualized. Fig.10 B contains an image from a single opti- 
cal section of a cell taken through the metaphase plate, which 
is  on  its  side.  Polymerized microtubules emanating  from 
three of the four spindle poles can be seen in this section. 
The darkened area in the center of these poles are the con- 
densed metaphase chromosomes. The fourth pole is out of 
the plane of the optical section shown. 
These results show that microtubule polymerization and 
spindle formation is not prevented in activated clam embryos 
treated with lovastatin. This indicates that the metaphase I 
arrest induced by inhibiting HMG-R activity is not due to the 
inability of these cells to polymerize their microtubules at a 
gross level. The spindles of activated clam oocytes treated 
with lovastatin and fixed at 50 min contained four poles in- 
stead of two. This suggests that inhibiting HMG-R activity 
during clam meiosis does not interrupt the splitting of the 
poles, which occurs normally in untreated, control samples 
before this time (Kuriyama et al., 1986). Normal splitting of 
the  spindle  poles  in  these  samples,  in  the  absence  of 
anaphase and cytokinesis, would be expected to give rise to 
a  spindle containing four poles as is seen. 
Discussion 
Inhibition of  HMG-R Blocks Cell Cycle 
Progression at Three Points during Meiosis in Clams 
and Stabilizes the Levels of  Cyclins and p34  ~2 
Kinase Activity 
This work demonstrates that inhibitors  of HMG-R act to 
induce a cell cycle arrest at three distinct points during meio- 
sis of clam embryos. When added to clam oocyte cultures 
before fertilization,  or until  3-6 rain after KC1 treatment, 
HMG-R inhibitors block activation reversibly. If these agents 
are added to synchronous cultures at times after activation, 
the  meiotic  cell  cycle continues  up  to  the  time of recta- 
phase when an arrest occurs accompanied by the mainte- 
nance of condensed chromosomes aligned on the metaphase 
plate.  Reversible cell  cycle arrest occurs at metaphase of 
meiosis I or II depending upon the time in the cell cycle at 
which  these  HMG-R  inhibitors  are  added.  The  addition 
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affect microtubule polymerization,  spindle formation or spindle 
pole splitting. Clam oocytes were activated by KCI treatment and, 
at 12 rain after KCI addition, were incubated in the presence of 
lovastatin to induce a metaphase I arrest. At 50 rain, oocytes were 
fixed and prepared for indirect immtmofluorescence staining using 
anti-tubulin antibodies.  Samples were mounted for fluorescence 
viewing by confocal microscopy. (A) Three different optical sec- 
tions (5/~m each) of  a single cell in which the four poles of  the spin- 
die can be visualized. (B) A 5-/~m  optical section that slices through 
the metaphase plate, which is on its side, is shown. Three of the 
four spindle poles present can be seen. Bar length is 20 I~M. 
of the HMG-R inhibitors to clam cultures,  after the time 
windows of sensitivity, has no effect on the ability of these 
cells to complete meiosis or to undergo the subsequent mi- 
totic divisions, indicating that these agents are not toxic and 
that their effects on the cell cycle in this biological system ap- 
pear to be meiosis-specific. The cell cycle effects of these in- 
hibitors  in  clams  are  unique.  No  other agents,  including 
those  which  inhibit macromolecular synthesis,  have been 
identified which trigger these effects. 
In clam embryos, to which HMG-R inhibitors have been 
added at a time to induce a metaphase I arrest, the levels of 
cyclins A, B, and p34  °d~2 kinase activity do not change over 
time,  but are stabilized at levels that are similar to those 
found in untreated cultures at the time of metaphase I. Total 
p34  cd~ kinase activity, assayed directly in extracts, or activ- 
ity  from  subpopulations  of  p34  ~2,  assayed  in  immune 
precipitates with cyclins A or B, or in p13  ~  precipitates, is 
maintained at high levels in cells arrested at metaphase I by 
treatment  with  HMG-R  inhibitors.  The  work  of several 
groups indicates that the inactivation of p34  °de2, which oc- 
curs normally at the end of M phase, is an important event 
for the exit from M phase and requires cyclin destruction. 
In these experiments, truncated,  non-degradable forms of 
cyclins A or B were introduced in intact cells or in cell-cycle 
extracts, and shown to prevent the inactivation of p34  ~da ki- 
nase activity, chromosome decondensation,  spindle disas- 
sembly, and cytokinesis (Murray et al., 1989; Ghiara et al., 
1991; Luca et al.,  1991; Gallant and Nigg,  1992; Verde et 
al.,  1992). It is likely that the stabilization of p34  ~2 kinase 
activity and the metaphase arrest that is induced in activated 
clam embryos treated with HMG-R inhibitors is due to the 
effects of these  agents  in  stabilizing  the  cyclin proteins. 
Stabilization of the cyclins in these embryos indicates that 
the activity of HMG-R is required somewhere upstream for 
the enactment of the normal cellular processes which lead 
to cyclin proteolysis. 
The Maintenance of  Metaphase I Arrest 
Induced by HMG--R Inhibition Does Not Require 
Protein Synthesis Nor the Maintenance 
of  Activated 1742 MAP Kinase 
A natural arrest at metaphase of meiosis I occurs normally 
in the development of female gametes for several species 
(Zampetti et eL1., 1973;  Guerrier et al.,  1986;  Dube and 
Dufresne, 1990). Maintenance of this metaphase I arrest, in 
oocytes from these species, appears to be dependent upon 
continued protein synthesis (Zampetti et al.,  1973;  Neant 
and Guerrier, 1988; Dube and Dufresne, 1990). In the case 
of the mollusk, Patella vulgata, this requirement for protein 
synthesis in maintenance of the metaphase I arrest appears 
to be a  requirement for cyclin synthesis since microinjec- 
tion of anti-sense oligonucleotides complementary to cyclin 
mRNAs releases this cell cycle block (van Loon et al., 1991). 
In contrast, the metaphase I arrest that is triggered in clam 
embryos by treatment with lovastatin does not require con- 
tinued protein synthesis.  Lovastatin-treated clam embryos, 
in which protein synthesis is inhibited, arrest at metaphase 
of meiosis  I  and  maintain  stable  levels  of cyclin B  and 
p34  ~2 kinase activity. The presence of cyclin A  is not re- 
quired for the maintenance of the metaphase I arrest, since 
it is absent from these embryos. The maintenance of cyclin 
B levels in these embryos, in the absence of protein synthe- 
sis,  indicates that its continued synthesis is not required for 
the maintenance of the metaphase I arrest and that a com- 
plete block to those processes which lead to cyclin proteoly- 
sis is induced by the inhibition of HMG-R activity. 
For many vertebrate species, the natural arrest point of the 
female gamete is at metaphase of meiosis II. This arrest is 
due to the cytoplasmic activity, cytostatic factor (CSF), first 
identified in Xenopus eggs (Masui and Markert,  1971) and 
is accompanied by stabilized levels of the cyclin proteins and 
the activities of p34  ~2 kinase and MAP kinase (Ferrell et 
al., 1991; Gotoh et al., 1991a,b; Posada et al., 1991; Zaitsev- 
skaya and Cooper,  1992). The CSF-induced metaphase ar- 
rest appears to be mediated through its activation and main- 
tenance of MAP kinase activity (Haccard et al.,  1993). 
In  activated clam embryos,  p42  M^PK is  transiently acti- 
vated, as a one-time event, before meiosis I (Shibuya et al., 
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in embryos treated with lovastatin at times which induce a 
downstream arrest at metaphase I. In these cells, then, in 
contrast to what may be required for a CSF-type of arrest, 
the activation and maintenance of p42 M^PK activity is not re- 
quired for the maintenance of metaphase arrest, nor for the 
stabilization of high levels of p34  ~2 kinase activity. 
Mechanisms of  Action  for HMG-R Inhibitors 
Two types of HMG-R inhibitors mainly are used in this 
study, lovastatin and PD123588.  Both lovastatin, which is 
isolated as a fungal metabolite (Alberts et al., 1980; Endo, 
1980) and PD123588,  which is synthetically derived (com- 
pound 10 in [Sliskovic et al.,  1990]),  were developed in- 
dependently for use as drugs effective in lowering plasma 
cholesterol in hypercholesterolemic patients. They act to in- 
hibit  HMG-R,  a  microsomal  enzyme that  catalyzes the 
reduction of HMG-CoA to mevalonate, which is the rate- 
limiting step in the synthesis of cholesterol (Goldstein and 
Brown, 1977). In independent tests, the effectiveness of  these 
compounds to inhibit HMG-R has been carried out and com- 
pared to that of  compactin, another HMG-R inhibitor related 
to lovastatin. Lovastatin was found to be slightly more effec- 
tive than compactin in inhibiting HMG-R (Alberts et al., 
1980;  Endo,  1980),  whereas PD123588  was found to be 
equally effective (Sliskovic  et al.,  1990). 
The structural commonalities found in all HMG-R inhibi- 
tors that have been developed lie in the presence of the upper 
part  of their  structures,  represented  by  lactone  ring  of 
lovastatin and PD123588  (Fig. 2). The active form of these 
inhibitors is produced by intracellular esterases that open 
this ring to create a  lactate, which resembles the hydrox- 
ymethylglutarate portion of HMG-CoA,  the  natural sub- 
strate of HMG-R. These compounds competitively inhibit 
the binding of HMG-CoA to HMG-R,  apparently by the 
binding  of  the  lactate  portion  of  the  inhibitors  to  the 
hydroxymethylglutarate-binding  domain in the active site of 
the enzyme (Nakamura and Abeles,  1985).  There is evi- 
dence to  suggest that the hydrophobic "lower portion" of 
these inhibitors, which varies widely in structure, binds to 
a  hydrophobic  region  of HMG-R  located  near,  but  not 
within, the active site (Nakamura and Abeles,  1985).  Al- 
though effects of these inhibitors on molecular targets other 
than HMG-R have not been seen, were they to occur, it is 
likely that these effects would be mediated by the hydropho- 
bic lower portions. 
Lovastatin and PD123588, both very effective inhibitors of 
HMG-R (Alberts et al., 1980; Endo, 1980; Sliskovic et al., 
1990), are different  in the lower, hydrophobic portion of  their 
structures (Fig. 2).  Because of this, we would expect that 
possible effects they might have on cellular targets, other 
than HMG-R, would be different. The effects of these agents 
on the cell cycle of meiotically dividing clams, however, are 
identical. Thus, we think it highly likely that the effects of 
these agents in this biological system are due to their actions 
as HMG-R inhibitors. 
In clam oocytes treated with lovastatin, there is a build-up 
of HMG-CoA, as well as a second unidentified component. 
This suggests that the effects of the HMG-R inhibitors on ac- 
tivation, as well as on passage through meiotic metaphase, 
may be due either to a negative influence on these processes 
by a metabolite that lies upstream of mevalonate, the levels 
of which accumulate in the presence of these inhibitors, or 
to the lack of a  mevalonate-derived metabolite that is re- 
quired in a positive way for the enactment of  these processes. 
Although negative effects on cell cycle progression of HMG 
CoA or other upstream metabolites have not been noted be- 
fore, the increased intracellular levels of other metabolites 
in the mevalonate biosynthetic pathway have been seen to 
negatively influence the process of cell division in other cell 
types (Cuthbert and Lipsky, 1991). The use of agents that 
specifically block steps in this pathway upstream of HMG-R, 
as well as the development of electroporation methods for 
supplying HMG-R inhibitor-treated clam oocytes and em- 
bryos with mevalonate and mevalonate-derived compounds 
may shed light on this issue. 
Requirements of  HMCr-R Activity  for Activation 
An early event of clam oocyte activation is the activation of 
an MBP-phogphorylating activity, which is due to the com- 
bined activities of activated p42  ~'~ and p34  ~-2 (Shibuya et 
al.,  1992).  This  activity appears  in  oocytes within five 
minutes after fertilization or KCI treatment, which is before 
the  time of GVBD  that occurs  at  ,vl0  rain.  We looked 
directly for the activation of this MBP-phosphorylating ac- 
tivity in oocytes treated with KCI in the presence of HMG-R 
inhibitors and found none, indicating that the requirement of 
HMG-R activity is upstream of this process. 
The requirement for HMG-R for oocyte activation and 
GVBD may be species specific.  GVBD in Xenopus oocytes, 
after treatment with progesterone, the natural hormone that 
triggers activation of these cells,  is  not affected by prior 
microinjection of compactin, indicating that HMG-R activ- 
ity is not required for this process (Schafer et al.,  1989). 
However, there are indications that mevalonate-derived  com- 
pounds may be involved in particular signaling pathways that 
lead to GVBD in these oocytes. GVBD and meiosis can be 
triggered in Xenopus oocytes by treatment with insulin in- 
stead of progesterone. Insulin-induced meiosis of Xenopus 
oocytes apparently requires the activity of farnesyl transfer- 
ase, the enzyme which transfers the farnesol isoprenyl group 
to particular proteins, since microinjection of specific pep- 
tides, which act as inhibitors of this activity, block GVBD 
(Chang  et  al.,  1992).  The  protein(s)  that  become  far- 
nesylated in response to insulin, which act to trigger GVBD, 
have not been identified, but are  suspected to be ras-like 
proteins. The activity of endogenous ras is thought to be re- 
quired  for insulin-induced GVBD,  but  not progesterone- 
induced GVBD, since microinjection of  monoclonal antibod- 
ies to ras can inhibit GVBD after insulin treatment but not 
after progesterone treatment (Deshpande and Kung, 1987; 
Korn et al., 1987). In addition, microinjection of oncogenic 
ras protein into oocytes induces GVBD and meiosis (Birch- 
meier et al.,  1985;  Allende et al.,  1988).  The isoprenoid 
modification of ras is, apparently, functionally important in 
this  activity  since  qoinjection  of compactin  blocks  ras- 
induced, but not progesterone-induced, GVBD  (Schafer et 
al.,  1989).  Thus, the requirement of farnesylation activity 
for insulin-induced GVBD may be a requirement for an ac- 
tive ras-like protein, which is farnesylated after insulin treat- 
ment,  and  for  which  this  modification is  necessary  for 
function. 
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tion of clam oocytes. The release of clam oocytes from cell 
cycle arrest by fertilization or KCI treatment apparently re- 
quires  3-6  min of HMG-R activity. The requirement for 
HMG-R for this process perhaps is due to a requirement for 
synthesis of the isoprenoid that is used for modification of 
a protein(s), which may be ras-like, at the time of activation. 
In such a  scenario, since new protein synthesis is not re- 
quired for activation in clams (Hunt et al., 1992),  this pro- 
tein would have to be  premade and stored in a  non-iso- 
prenylated form in the oocyte, Fertilization or KC1 treatment 
would act  to  trigger the  synthesis and attachment of the 
isoprenoid modification of this protein, which would then be 
functionally able to initiate the process of activation. While 
this hypothesis is useful in that it provides a model that can 
be tested experimentally, it should be noted that, in those 
cases where it has been studied, protein prenylation appears 
to occur on targeted proteins directly after translation (see 
Clarke, 1992) and has not been seen to serve in a regulatory 
role for protein function. 
A required, early event for clam oocyte activation is the 
influx of calcium from the  external  environment (Allen, 
1953). The influx of calcinm after fertilization or KCI treat- 
ment is thought to be mediated through the opening of volt- 
age-gated  channels  by  a  transient  depolarization  (Finkel 
and Wolf,  1980).  However,  these channels have not been 
identified in the clam, nor have the mechanisms by which 
they are regulated been elucidated. The influx of Ca  ++ in 
mast cells after stimulation, which is required for the activa- 
tion of downstream signaling responses involved in inflam- 
matory mediator secretion, is inhibited by incubation with 
HMG-R inhibitors (Deanin et al., 1991). This inhibition is 
overcome by mevalonate but not by sterols, suggesting that 
a non-sterol mevalonate-derived compound is important, al- 
though this compound has not been identified, nor has the 
manner in which it influences the influx of Ca  ++ . It may be 
that similar compounds act to mediate the influx of Ca  ++ in 
clam oocytes after KC1 treatment or fertilization, a model 
that is experimentally testable. 
Requirements of HMG-R Activity for Meiotic Cell 
Cycle Progression 
In  activated  clam  oocytes,  treatment  with  inhibitors  of 
HMG-R induces a block to those processes that result in cy- 
clin proteolysis at metaphase I. Using cell-free systems in 
which programmed events of the mitotic cell cycle are faith- 
fully reproduced, it has been shown that the cell cycle-regu- 
lated degradation of the cyclins occurs via ubiquitin-medi- 
ated proteolysis (Glotzer et al., 1991; Hershko et al., 1991). 
Ubiquitin-mediated proteolysis of non-cyclin proteins ap- 
pears to occur as well at the metaphase/anaphase transition 
in mitosis, and is required for the separation of sister chro- 
matids during anaphase (Holloway et al.,  1993).  In clams, 
the enzymatic components of the ubiquitin system, which 
brings about cyclin destruction during mitosis, appear to be 
active during metaphase of meiosis I also (Hershko et al., 
1994).  The fact that inhibitors of HMG-R block the activa- 
tion of cyclin proteolysis and anaphase in activated clam oo- 
cytes, suggests that metabolites from the mevalonate biosyn- 
thetic pathway may act  upstream  to  influence either the 
activation of ubiquitin-mediated proteolysis during meiosis, 
or to render the cyclins, as well as other potential proteins, 
the destruction of which may be required for anaphase, avail- 
able to the action of the enzymes involved in proteolysis. 
However,  positive or negative influences of metabolites in 
the mevalonate biosynthetic pathway for the enzymatic steps 
of ubiquitin-mediated proteolysis have not been noted (for 
review see Hershko and Ciechanover,  1992). 
HMG-R itself  is an enzyme, the activity of  which is tightly 
regulated at several levels including that of protein turnover 
(for review see Goldstein and Brown, 1990). The proteolytic 
mechanisms by which HMG-R are degraded have not been 
elucidated, however recent studies (Sherwood et al.,  1993) 
indicate that there may be commonalities in the pathways of 
HMG-R proteolysis and those resulting in cyclin destruc- 
tion. In these studies, it was shown that treatment of cells 
with the cysteine protease inhibitor, N-acetylleucylleucyl- 
norleucinal, a known inhibitor of HMG-R proteolysis (Inoue 
et al., 1991) led to stabilization of cyclin B protein, with an 
accompanying stabilization ofhistone H1 kinase activity and 
metaphase arrest. It is of interest to note that proteolysis of 
HMG-R requires a non-sterol mevalonate derived compound 
and genetic studies in yeast indicate that this requirement 
may be for a  farnesylated protein (Roitelman and Simoni, 
1992;  Hampton and Rine, 1994).  There may be a require- 
ment for a mevalonate-derived component necessary for cy- 
clin destruction in activated clam oocytes during meiosis that 
may be similar to that needed for the pathway of HMG-R 
proteolysis. 
Requirements of HMG-R Activity for Cell Cycle 
Progression in Mitotically Dividing Cells 
Inhibition of mevalonate synthesis in a variety of mitotically 
dividing postembryonic cell types induces an arrest in the G1 
phase of the cell cycle (Coruell et al., 1977; Kaneko et al., 
1978;  Quesney-Huneeus et  al.,  1979;  Habenicht  et  al., 
1980; Perkins et al., 1982; Fairbanks et al., 1984; Sinensky 
and Logel, 1985; Doyle and Kandutsch, 1988; Chakrabarti 
and Engleman,  1991; Keyomarsi et al.,  1991). In contrast 
to the effects  seen in postembryonic cells, the addition of 
HMG-R inhibitors to early clam embryos does not affect 
their ability to divide mitotically. This finding is similar to 
what is seen for sea urchin embryos where progress through 
the early mitotic divisions is apparently unaffected by inhibi- 
tion of HMG-R (Carson and Lennarz, 1979). In these cells, 
no affects of inhibiting HMG-R are noted until the time of 
gastrulation,  which occurs  abnormally or,  for some em- 
bryos, is blocked. 
Why  would  inhibition  of  HMG-R  affect  the  passage 
through the two meiotic divisions, but not for the mitotic di- 
visions? It may be that the activity of HMG-R increases in 
clam embryos during mitosis, and so would still be active in 
the presence of inhibitor concentrations that would block 
meiosis. Such changes of HMG-R activity occurs in sea ur- 
chin embryos where there is a dramatic increase during early 
developmental  stages  (Woodward,  1988  #327).  Alterna- 
tively, there may be differential requirements of HMG-R ac- 
tivity for meiosis and mitosis. One major difference between 
the two meiotic divisions and the mitotic divisions is the ori- 
gin of the microtubule organizing centers (MTOCs), which 
are involved in producing the spindle poles.  The MTOCs 
which form the poles of the meiotic spindle are maternally 
derived, whereas those involved in the formation of the mi- 
totic spindle are brought in with the sperm at the time of fer- 
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mechanism  of  spindle  formation  during  meiosis  may  be 
different than during mitosis. This is suggested by studies in 
which differential  effects on meiotic  and  mitotic  spindles 
are seen  following  treatments  with  taxol,  a  microtubule- 
stabilizing agent (Kuriyama,  1986).  It may be that metabo- 
lites from the mevalonate biosynthetic pathway influence the 
formation of the spindle during  meiosis, but not mitosis. 
Microtubule Polymerization, Spindle Formation, and 
Feedback Controls 
Postembryonic cells have in place a checkpoint mechanism 
that prevents the exit from M phase until the chromosomes 
are aligned properly on the metaphase plate of the spindle 
(for review see Murray,  1992).  This checkpoint is enacted 
in cells that are treated with agents,  which disrupt the spin- 
dle,  thereby  preventing  proper chromosome  alignment  at 
metaphase.  Such treatments  bring about a cell cycle arrest 
at metaphase accompanied by the stabilization of cyclin B 
and p34  cd¢~ kinase  activity.  In  clam  embryos,  this  check- 
point appears to operate, since treatment  with microtubule 
depolymerizing  agents  to  disrupt  the  spindle  results  in a 
metaphase arrest of either meiosis or mitosis (Hunt ct al., 
1992 and K.  Swcnson, unpublished). 
Inhibition of HMG-R in activated clam oocytes to induce 
a metaphase  arrest  at meiosis I does not appear  to affect 
microtubule polymerization, spindle formation, or chromo- 
some alignment. This indicates that the metaphase arrest in 
these  cells  is  not  being  triggered  by  alterations  of these 
processes, at least at a gross level. In other cell types as well, 
microtubule polymerization does not appear to be affected 
by HMG-R inhibitors (Fenton et al.,  1992). 
When activated  clam oocytes arrested  at metaphase I by 
HMG-R inhibition are fixed at 50 min postactivation, a time 
when control cultures arc undergoing anaphase of meiosis II, 
the spindles are  quadripolar  instead of bipolar.  If spindle 
pole splitting  occurred normally in the absence of anaphase 
or cytokinesis CKuriyama et al.,  1986),  the formation of a 
quadripolar  spindle at 50 min postactivation would be ex- 
pected. Our results  suggest that HMG-R inhibition of acti- 
vated clam oocytes, while blocking anaphase  and cytokinc- 
sis,  does not affect the  normal  splitting  of spindle poles. 
Treatments  which delay progress through  mitosis in other 
cell types have been seen to induce multipolar spindles as 
well CKeryer ct al.,  1984;  Sludcr and Begg,  1985;  Gallant 
and Nigg,  1992). 
In yeasts, mutants of genes that function in mediating the 
checkpoint that operates as a feedback control during mitosis 
have been isolated (Hoyt et al., 1991; Li and Murray, 1991). 
These mutants  were obtained in screens as ones which fail 
to delay the onset of anaphase  in the presence of spindle 
damage  caused by  the  microtubule  depolymerizing  drug, 
benomyl. To date, none of the products encoded by the genes 
which are affected by these mutations appear to be regulated 
by metabolites of the mevalonate biosynthetic pathway. Our 
results suggest that, during clam meiosis, either the build-up 
of metabolites from this pathway upstream of mevalonate, or 
the  absence  of a  mevalonate-derived  metabolite,  is nega- 
tively influencing passage through  the metaphase/armphase 
transition.  It may be that the metaphase arrest that occurs in 
these cells  is due to  the triggering  of checlcpoint  control 
processes. 
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